Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells

Anticancer Research

Volumn 21, Issue 2 A, 2001, Pages 1189-1194

  Lavie, Y ^a   Harel Orbital, T ^a   Gaffield, W ^a   Liscovitch, M ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Alkaloids; Cancer; Cyclopamine; Multidrug resistance; NCI AdrR cells; Steroidal; Tomatidine

Indexed keywords

ALKALOID; ANTINEOPLASTIC AGENT; CARRIER PROTEIN; CYTOTOXIC AGENT; DOXORUBICIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; SOLANIDINE; STEROID; VERAPAMIL; VINBLASTINE;

ADENOCARCINOMA; ARTICLE; CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CELL SURVIVAL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT FAILURE; TUMOR CELL; VERATRUM;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HETEROCYCLIC COMPOUNDS, 3-RING; HUMANS; MOLECULAR STRUCTURE; P-GLYCOPROTEIN; SOLANACEOUS ALKALOIDS; TOMATINE; TUMOR CELLS, CULTURED; VERATRUM ALKALOIDS; VINBLASTINE;

EID: 0035015140     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. How cancer cells evade chemotherapy, sixteenth Richard and Hinda Rosenthal foundation award lecture
2. P-glycoprotein: Its role in multidrug resistance
3. Molecular dissection of the human multidrug resistance P- glycoprotein
4. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
5. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs
6. Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver
7. A multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells
8. Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?
9. MDR1 reversal: Criteria for clinical trials designed to overcome the multidrug resistance phenotype
10. Clinical trials of P-glycoprotein reversal in solid tumours
11. Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (Valspodar)
12. Cyclopamine and related steroidal alkaloid teratogens: Their occurrence, structural relationship, and biologic effects
13. Induction of terata in hamsters by solanidane alkaloids derived from Solanum tuberosum
14. Multiple roles of cholesterol in hedgehog protein biogenesis and signaling
15. Role of multidrug resistance P-glycoproteins in cholesterol biosynthesis
16. Carbon-13 and proton nuclear magnetic resonance spectra of Veratrum alkaloids
17. Isolation of amplified and overexpressed DNA sequences from adriamycinresistant human breast cancer cells
18. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi
19. Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug resistant cells is determined by their passive transmembrane movement rate
20. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill
21. Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein
22. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus
23. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities
24. (+)-V erussurine, a new steroidal alkaloid from the roots and rhizomes of Veratrum nigrum var ussuriense and structure revision of (+)-verabenzoa-mine1
25. Cancer multidrug resistance